ARTEMISMED347.00

Artemis Medicare Services Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersINDRAMEDCOSHALBYGKSLGPTHEALTHLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹5,493 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations878.6936.91,081.21,113.6
Other Income7.433.029.828.3
Total Income885.9969.91,111.11,141.9
Expenses
+ Cost of Materials Consumed218.7227.4253.9249.1
+ Changes in Inventories0.00.00.00.0
+ Employee Benefit Expense138.9148.4166.1170.5
+ Finance Costs31.331.927.726.8
+ Depreciation & Amortisation40.345.248.149.6
+ Other Expenses388.3409.3473.1490.8
Total Expenses817.5862.2968.8986.8
EBITDA132.7151.8188.2203.2
EBIT92.4106.6140.1153.6
Profit
PBT before Exceptional Items68.5107.7142.3155.1
+ Exceptional Items0.00.0-3.1-3.1
Pretax Income68.5107.7139.2152.0
+ Current Tax12.721.329.032.3
+ Deferred Tax6.74.26.45.7
Tax Expense19.325.535.538.1
Net Income49.182.2103.7114.0
+ Net Income — Continuing Ops49.182.2103.7114.0
+ Other Comprehensive Income-0.2-0.1-0.2-0.2
Total Comprehensive Income49.082.1103.5113.8
Net Income to Common49.182.6103.6113.7
Minority Interest0.0-0.40.10.3
Per Share
Basic EPS3.625.376.567.19
Diluted EPS3.535.316.567.18
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.1-0.2-0.2
+ Items NOT to be Reclassified to P&L-0.4-0.3-0.4-0.4
+ Tax on Items NOT to be Reclassified-0.2-0.2-0.2
+ Tax on Items NOT to be Reclassified — alt tag-0.3
Comprehensive Income — Owners of Parent49.082.5103.4113.5
Comprehensive Income — Non-controlling Interests0.0-0.50.10.3
Per Share — as-filed variants
Basic EPS — Continuing Operations3.625.376.567.19
Diluted EPS — Continuing Operations3.535.316.567.18
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit659.9709.5827.4864.5
Gross Margin %75.1175.7276.5277.63
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)68.5107.7142.3155.1
− Exceptional Items (reconciliation)0.00.0-3.1-3.1
Net Income Adj (tax-effected)49.182.2106.0116.3
EPS Adj3.625.376.707.34
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Paid Up Equity Capital13.613.815.815.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.